L'intérêt à découvert sur Theravance Biopharma Inc (NASDAQ:TBPH) a diminué lors de la dernière période de déclaration, augmentant de en baisse de 5.13M à 4.95M. Cela représente 15.84% des actions disponibles au public de l'entreprise.
L'intérêt à découvert pour Theravance Biopharma Corp (XNAS:TBPH) a diminué au cours de la dernière période de référence, passant de 280,30 M à 275,20 M. Cela a mis 1,17 % des actions de la société disponibles au public en position courte.
Sur la base du volume moyen récent de 344.58K actions échangées par jour, il faudrait 14.36 jour(s) aux détenteurs de cet intérêt à découvert pour clôturer leurs positions sans faire monter brusquement le cours de l'action.
Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|
TBPH | Theravance Biopharma, Inc. Ord | 09/30/2025 | 10/09/2025 | 15.84% | 31,234,086 | 4,946,762 | 344,583 | 14.36 | |
TBPH | Theravance Biopharma, Inc. Ord | 09/15/2025 | 09/24/2025 | 16.41% | 31,234,086 | 5,125,615 | 566,610 | 9.05 | |
TBPH | Theravance Biopharma, Inc. Ord | 08/29/2025 | 09/10/2025 | 14.28% | 31,234,086 | 4,460,825 | 536,961 | 8.31 | |
TBPH | Theravance Biopharma, Inc. Ord | 08/15/2025 | 08/26/2025 | 11.39% | 31,234,086 | 3,558,770 | 428,001 | 8.31 | |
TBPH | Theravance Biopharma, Inc. Ord | 07/31/2025 | 08/11/2025 | 13.36% | 30,874,122 | 4,123,585 | 156,429 | 26.36 | |
TBPH | Theravance Biopharma, Inc. Ord | 07/15/2025 | 07/24/2025 | 12.78% | 30,874,122 | 3,945,366 | 159,627 | 24.72 | |
TBPH | Theravance Biopharma, Inc. Ord | 06/30/2025 | 07/10/2025 | 13.48% | 30,874,122 | 4,162,817 | 275,881 | 15.09 | |
TBPH | Theravance Biopharma, Inc. Ord | 06/13/2025 | 06/25/2025 | 12.88% | 30,874,122 | 3,977,181 | 452,535 | 8.79 | |
TBPH | Theravance Biopharma, Inc. Ord | 05/30/2025 | 06/10/2025 | 12.28% | 30,874,122 | 3,790,310 | 220,552 | 17.19 | |
TBPH | Theravance Biopharma, Inc. Ord | 05/15/2025 | 05/27/2025 | 13.05% | 30,874,122 | 4,029,761 | 350,890 | 11.48 | |
TBPH | Theravance Biopharma, Inc. Ord | 04/30/2025 | 05/09/2025 | 15.37% | 25,315,528 | 3,889,972 | 216,513 | 17.97 | |
TBPH | Theravance Biopharma, Inc. Ord | 04/15/2025 | 04/25/2025 | 14.22% | 25,315,528 | 3,598,867 | 240,800 | 14.95 | |
TBPH | Theravance Biopharma, Inc. Ord | 03/31/2025 | 04/09/2025 | 14.09% | 25,315,528 | 3,566,516 | 178,083 | 20.03 | |
TBPH | Theravance Biopharma, Inc. Ord | 03/14/2025 | 03/25/2025 | 14.46% | 25,315,528 | 3,661,778 | 243,667 | 15.03 | |
TBPH | Theravance Biopharma, Inc. Ord | 02/28/2025 | 03/11/2025 | 14.73% | 25,315,528 | 3,728,702 | 399,460 | 9.33 | |
TBPH | Theravance Biopharma, Inc. Ord | 02/14/2025 | 02/26/2025 | 15.55% | 25,315,528 | 3,937,371 | 161,399 | 24.4 | |
TBPH | Theravance Biopharma, Inc. Ord | 01/31/2025 | 02/11/2025 | 15.84% | 25,315,528 | 4,010,829 | 238,696 | 16.8 | |
TBPH | Theravance Biopharma, Inc. Ord | 01/15/2025 | 01/27/2025 | 15.65% | 25,315,528 | 3,960,631 | 159,867 | 24.77 | |
TBPH | Theravance Biopharma, Inc. Ord | 12/31/2024 | 01/10/2025 | 15.45% | 25,315,528 | 3,911,157 | 171,534 | 22.8 | |
TBPH | Theravance Biopharma, Inc. Ord | 12/13/2024 | 12/24/2024 | 16.09% | 25,315,528 | 4,072,705 | 201,693 | 20.19 | |
TBPH | Theravance Biopharma, Inc. Ord | 11/29/2024 | 12/10/2024 | 17.05% | 25,315,528 | 4,317,167 | 245,697 | 17.57 | |
TBPH | Theravance Biopharma, Inc. Ord | 11/15/2024 | 11/26/2024 | 19.17% | 25,315,528 | 4,852,704 | 206,101 | 23.55 | |
TBPH | Theravance Biopharma, Inc. Ord | 10/31/2024 | 11/11/2024 | 19.64% | 25,063,315 | 4,922,641 | 119,854 | 41.07 | |
TBPH | Theravance Biopharma, Inc. Ord | 10/15/2024 | 10/24/2024 | 20.10% | 25,063,315 | 5,036,784 | 186,124 | 27.06 | |
TBPH | Theravance Biopharma, Inc. Ord | 09/30/2024 | 10/09/2024 | 20.90% | 25,063,315 | 5,237,799 | 220,636 | 23.74 | |
TBPH | Theravance Biopharma, Inc. Ord | 09/13/2024 | 09/24/2024 | 21.38% | 25,063,315 | 5,357,530 | 206,023 | 26 | |
TBPH | Theravance Biopharma, Inc. Ord | 08/30/2024 | 09/11/2024 | 21.68% | 25,063,315 | 5,432,635 | 224,665 | 24.18 | |
TBPH | Theravance Biopharma, Inc. Ord | 07/31/2024 | 08/09/2024 | 21.77% | 25,063,315 | 5,455,870 | 318,680 | 17.12 | |
TBPH | Theravance Biopharma, Inc. Ord | 07/15/2024 | 07/24/2024 | 22.77% | 24,774,456 | 5,642,020 | 364,278 | 15.49 | |
TBPH | Theravance Biopharma, Inc. Ord | 06/28/2024 | 07/10/2024 | 23.67% | 24,774,456 | 5,863,734 | 482,604 | 12.15 | |
TBPH | Theravance Biopharma, Inc. Ord | 06/14/2024 | 06/26/2024 | 25.39% | 24,774,456 | 6,291,069 | 263,598 | 23.87 | |
TBPH | Theravance Biopharma, Inc. Ord | 05/31/2024 | 06/11/2024 | 24.27% | 24,774,456 | 6,011,856 | 343,507 | 17.5 | |
TBPH | Theravance Biopharma, Inc. Ord | 05/15/2024 | 05/24/2024 | 23.76% | 24,774,456 | 5,885,262 | 488,958 | 12.04 | |
TBPH | Theravance Biopharma, Inc. Ord | 04/30/2024 | 05/09/2024 | 24.87% | 24,774,456 | 6,160,458 | 342,838 | 17.97 | |
TBPH | Theravance Biopharma, Inc. Ord | 04/15/2024 | 04/24/2024 | 26.03% | 24,701,187 | 6,429,741 | 460,201 | 13.97 | |
TBPH | Theravance Biopharma, Inc. Ord | 03/28/2024 | 04/09/2024 | 30.45% | 24,701,187 | 7,520,374 | 369,085 | 20.38 | |
TBPH | Theravance Biopharma, Inc. Ord | 03/15/2024 | 03/26/2024 | 41.72% | 20,142,296 | 8,404,365 | 342,525 | 24.54 | |
TBPH | Theravance Biopharma, Inc. Ord | 02/29/2024 | 03/11/2024 | 42.77% | 20,142,296 | 8,614,538 | 336,609 | 25.59 | |
TBPH | Theravance Biopharma, Inc. Ord | 01/31/2024 | 02/09/2024 | 38.32% | 21,775,454 | 8,343,666 | 262,875 | 31.74 | |
TBPH | Theravance Biopharma, Inc. Ord | 01/12/2024 | 01/24/2024 | 39.22% | 21,775,454 | 8,540,338 | 554,621 | 15.4 | |
TBPH | Theravance Biopharma, Inc. Ord | 12/29/2023 | 01/10/2024 | 40.93% | 21,775,454 | 8,913,400 | 357,400 | 24.94 | |
TBPH | Theravance Biopharma, Inc. Ord | 12/15/2023 | 12/27/2023 | 42.82% | 21,775,454 | 9,324,381 | 503,217 | 18.53 | |
TBPH | Theravance Biopharma, Inc. Ord | 11/30/2023 | 12/11/2023 | 42.86% | 21,775,454 | 9,333,777 | 325,649 | 28.66 | |
TBPH | Theravance Biopharma, Inc. Ord | 11/15/2023 | 11/27/2023 | 41.70% | 21,775,454 | 9,079,970 | 432,611 | 20.99 | |
TBPH | Theravance Biopharma, Inc. Ord | 10/31/2023 | 11/09/2023 | 36.16% | 24,790,692 | 8,964,966 | 353,197 | 25.38 | |
TBPH | Theravance Biopharma, Inc. Ord | 10/13/2023 | 10/24/2023 | 36.31% | 24,790,692 | 9,000,562 | 347,854 | 25.87 |
À la recherche des actions les plus vendues à découvert?